Adults with type 2 diabetes will have a new alternative to daily insulin injections now that the U.S. Food and Drug Administration (FDA) approved a new once-a-week insulin injection.
Governor Greg Abbott delivered remarks at the groundbreaking ceremony for Eli Lilly and Company’s $6.5 billion active ...
Eli Lilly's new $6.5 billion facility in Houston will enhance pharmaceutical production and active ingredient manufacturing, part of a $50 billion ...
Eli Lilly and Co. stock (ISIN US5324571083) closed at USD 1,172.05 on the NYSE on September 22, 2026, up 0.61 percent from ...
Sign-ups for Medicare’s GLP-1 coverage plan keep expanding, and Eli Lilly is dominating the market with 70% share, the company’s CEO David Ricks said. | Sign-ups for Medicare’s GLP-1 coverage plan ...
Amid a $50 billion plan to reshore medicine production, Eli Lilly broke ground on a $6.5 billion manufacturing plant in ...
KHOU-TV Houston on MSN
Eli Lilly campus going up in Houston
6.5 billion dollar project ...
The FDA took issue with the volume of GLP-1 drugs that Empower produces, suggesting in the warning letter that the changes do ...
Eli Lilly has broken ground on a $6.5B Houston facility expected to create thousands of jobs and manufacture its oral GLP-1 ...
McCord Development is attracting some of the biggest names in advanced manufacturing to the 4,300-acre Generation Park, and ...
Eli Lilly and Company has broken ground on a $6.5 billion manufacturing facility in Houston, Texas, marking another milestone ...
Eli Lilly stock edges higher today, trading at $1,170. The company announces a new $6.5 billion manufacturing site in Houston ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results